SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045888
Filing Date
2024-11-14
Accepted
2024-11-14 16:15:34
Documents
70
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1112287
2 ex31-1.htm EX-31.1 17749
3 ex31-2.htm EX-31.2 17741
4 ex32-1.htm EX-32.1 6688
5 ex32-2.htm EX-32.2 6724
  Complete submission text file 0001493152-24-045888.txt   6056455

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20240930.xsd EX-101.SCH 42901
7 XBRL CALCULATION FILE vvos-20240930_cal.xml EX-101.CAL 58318
8 XBRL DEFINITION FILE vvos-20240930_def.xml EX-101.DEF 193808
9 XBRL LABEL FILE vvos-20240930_lab.xml EX-101.LAB 343987
10 XBRL PRESENTATION FILE vvos-20240930_pre.xml EX-101.PRE 292817
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 958354
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 241462522
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)